Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Breast Cancer
Interventions
DRUG

Fulvestrant

250mg on d1,15,29 or 250mg on d1 q28days

Trial Locations (9)

Unknown

"Ag.Georgios General Hospital of Chania", Chania

University Hospital of Crete, Dep of Medical Oncology, Heraklion

University General Hospital of Alexandroupolis, Dep of Medical Oncology, Alexandroupoli

"Agios Savvas Anticancer Hospital of Athens", Athens

401 Military Hospital of Athens, Athens

Air Forces Military Hospital of Athens, Athens

IASO General Hospital of Athens, 1st Dep of Medical Oncology, Athens

State General Hospital of Larissa, Dep of Medical Oncology, Larissa

Theagenion Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology, Thessaloniki

All Listed Sponsors
lead

Hellenic Oncology Research Group

OTHER